Article
Significant improvement of a nevus spilus-type congenital melanocytic nevus with oral selumetinib.
Pediatric dermatology - 1 Jan 2000
Berna R, Hasbun T, Adams D, Moon A T, Treat J R
Abstract excerpt
Giant congenital melanocytic nevi (GCMN) can be cosmetically significant and can lead to melanoma. There is no standard pharmacologic treatment for GCMN. We present the case of an 8-year-old female with kaposiform lymphangiomatosis caused by an NRAS mutation whose nevus spilus-type GCMN improved on oral selumetinib.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.